+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cancer Biomarkers Market Analysis 2019

  • ID: 4857828
  • Report
  • October 2019
  • Region: Global
  • 151 pages
  • Syngene Research
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux SA
  • Danaher Corporation
  • Hologic
  • Merck & Co
  • Qiagen N.V.
  • MORE
The Global Cancer Biomarkers market is expected to reach $37.99 billion by 2026 growing at a CAGR of 14.2% from 2018 to 2026. Cancer biomarkers are detectable substances that can be utilized as an indicator of biological condition of tumor and subsequently it may be utilized to examine diagnostic and prognostic phases of cancer. The prevention of cancer by diagnosing and analyzing various cancer biomarkers utilizing different diagnostic strategies is a significant methodology for acquiring fast outcomes for treatment. These biomarkers are utilized as risk indicators for different cancer for example, lung cancer, breast cancer, and prostate cancer among others.

Factors such as rise in technological advancements and increase in Incidence of Cancer diseases are driving the market growth. Though, high capital investment and technical issues related to sample collection and storage are projected to inhibit the growth of the market. Moreover, emerging economies and personalized medicine may provide ample opportunities for the market growth.

By biomarker type, protein biomarkers segment acquired significant growth in the market is mainly attributed to the tremendous capability of protein biomarkers in cancer detection, diagnostics, prognostics, and clinical & therapeutic applications; and minimal cost of the protein biomarker tests as contrasted with genetic biomarker tests. The rising focus of pharmaceutical organizations towards the discovery of protein biomarkers is additionally expected to fuel the development of this market during the forecast period.

The key vendors mentioned are Qiagen N.V., Thermo Fisher Scientific, GE Healthcare, Roche Diagnostics, Abbott Laboratories, Illumina, Danaher Corporation, Agilent Technologies, Sysmex Corporation, Merck & Co., Quest Diagnostics, Becton, Dickinson and Company, Hologic, Myriad Genetics, Bio-Rad Laboratories and Biomérieux SA .

Categories Covered:
  • Cancer Biomakers of Disease
  • Cancer Biomakers of Exposure
Methods Covered:
  • Assay Development
  • Biomarkers and Testing
  • Sample Preparation
Biomarker Types Covered:
  • Cancer Antigen 15-3 (CA 15-3)
  • Cancer Antigen 27-29 (CA27-29)
  • Carbohydrate Antigen 19-9 (CA 19-9)
  • Carcinoembryonic antigen (CEA)
  • Epigenetic Biomarkers
  • Genetic Biomarkers
  • Glass Transition Temperature (Tg)
  • Glyco-biomarkers
  • Glycomic Biomakers
  • Glycoprotein Biomarkers
  • Human Chorionic Gonadotropin (Hcg)
  • Human Epidermal Growth Factor Receptor 2 (HER2)
  • Human Epididymis Protein 4 (HE4)
  • Metabolic Biomakers
  • Microsatellite Instability (MSI) / Measles, Mumps and Rubella (MMR)
  • Protein Biomarkers
  • Proteomic Biomarkers
  • Risk of Ovarian Malignancy Algorithm (ROMA)
  • Tumor Mutational Burden (TMB)
  • Tumor-Infiltrating Lymphocytes (TILs)
Cancer Types Covered:
  • Bladder Cancer
  • Blood Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer (CRC)
  • Kidney Cancer
  • Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Non-Hodgkin’s Lymphoma
  • Ovarian Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Thyroid Cancer
Technologies Covered:
  • Bioinformatics
  • Cytogenetics-based Tests
  • Imaging Technologies
  • Immunoassays
  • IVD Multivariate Index Assays
  • Omic technologies
Test Types Covered:
  • Alpha-Fetoprotein (AFP) Tests
  • Anaplastic Lymphoma Receptor Tyrosine Kinase Gene (ALK) Tests
  • BReast CAncer gene (BRCA) Tests
  • Cancer Antigen (CA) Tests
  • Carcinoembryonic Antigen (CEA) Tests
  • Circulating Tumor Cell (CTC) Tests
  • Companion Diagnostic Tests (CDx)
  • Estimated Glomerular Filtration Rate (EGFR) Mutation Tests
  • Human Epidermal Growth Factor Receptor 2 (HER2) Tests
  • Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation Tests
  • Laboratory Developed Tests (LDTs)
  • Prostate-specific Antigen (PSA) Tests
Analytical Techniques Covered:
  • Immunohistochemistry (IHC)
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
Products Covered:
  • cDNA clone based
  • ELISA pair sets based
  • RNA based
  • Tumor suppressor based
Applications Covered:
  • Development and Drug Formulation
  • Development of Molecular Diagnostics
  • Disease Diagnostics
  • Drug Discovery and Development
  • Personalised Medicine
  • Predictive
  • Prognostics
  • Research and Development
  • Risk Assessment
  • Therapeutic
End-Users Covered:
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagonostic Centers and Reasearch Laboratories
  • Clinic Laboratories
  • Contract Research Organizations(CRO)
  • Healthcare IT/Big Data Companies
  • Hospitals
  • Pharma & Biotech Companies
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux SA
  • Danaher Corporation
  • Hologic
  • Merck & Co
  • Qiagen N.V.
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Cancer Biomarkers Market, By Category
5.1 Introduction
5.2 Cancer Biomakers of Disease
5.3 Cancer Biomakers of Exposure

6 Global Cancer Biomarkers Market, By Method
6.1 Introduction
6.2 Assay Development
6.3 Biomarkers and Testing
6.4 Sample Preparation

7 Global Cancer Biomarkers Market, By Biomarker Type
7.1 Introduction
7.2 Cancer Antigen 15-3 (CA 15-3)
7.3 Cancer Antigen 27-29 (CA27-29)
7.4 Carbohydrate Antigen 19-9 (CA 19-9)
7.5 Carcinoembryonic antigen (CEA)
7.6 Epigenetic Biomarkers
7.7 Genetic Biomarkers
7.8 Glass Transition Temperature (Tg)
7.9 Glyco-biomarkers
7.10 Glycomic Biomakers
7.11 Glycoprotein Biomarkers
7.12 Human Chorionic Gonadotropin (Hcg)
7.13 Human Epidermal Growth Factor Receptor 2 (HER2)
7.14 Human Epididymis Protein 4 (HE4)
7.15 Metabolic Biomakers
7.16 Microsatellite Instability (MSI) / Measles, Mumps and Rubella (MMR)
7.17 Protein Biomarkers
7.18 Proteomic Biomarkers
7.19 Risk of Ovarian Malignancy Algorithm (ROMA)
7.20 Tumor Mutational Burden (TMB)
7.21 Tumor-Infiltrating Lymphocytes (TILs)

8 Global Cancer Biomarkers Market, By Cancer Type
8.1 Introduction
8.2 Bladder Cancer
8.3 Blood Cancer
8.4 Breast Cancer
8.5 Cervical Cancer
8.6 Colorectal Cancer (CRC)
8.7 Kidney Cancer
8.8 Leukemia
8.9 Liver Cancer
8.10 Lung Cancer
8.11 Melanoma
8.12 Non-Hodgkin’s Lymphoma
8.13 Ovarian Cancer
8.14 Prostate Cancer
8.15 Stomach Cancer
8.16 Thyroid Cancer

9 Global Cancer Biomarkers Market, By Technology
9.1 Introduction
9.2 Bioinformatics
9.3 Cytogenetics-based Tests
9.4 Imaging Technologies
9.5 Immunoassays
9.6 IVD Multivariate Index Assays
9.7 Omic technologies

10 Global Cancer Biomarkers Market, By Test Type
10.1 Introduction
10.2 Alpha-Fetoprotein (AFP) Tests
10.3 Anaplastic Lymphoma Receptor Tyrosine Kinase Gene (ALK) Tests
10.4 BReast CAncer gene (BRCA) Tests
10.5 Cancer Antigen (CA) Tests
10.6 Carcinoembryonic Antigen (CEA) Tests
10.7 Circulating Tumor Cell (CTC) Tests
10.8 Companion Diagnostic Tests (CDx)
10.9 Estimated Glomerular Filtration Rate (EGFR) Mutation Tests
10.10 Human Epidermal Growth Factor Receptor 2 (HER2) Tests
10.11 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation Tests
10.12 Laboratory Developed Tests (LDTs)
10.13 Prostate-specific Antigen (PSA) Tests

11 Global Cancer Biomarkers Market, By Analytical Technique
11.1 Introduction
11.2 Immunohistochemistry (IHC)
11.3 Next Generation Sequencing (NGS)
11.4 Polymerase Chain Reaction (PCR)

12 Global Cancer Biomarkers Market, By Product
12.1 Introduction
12.2 cDNA clone based
12.3 ELISA pair sets based
12.4 RNA based
12.5 Tumor suppressor based

13 Global Cancer Biomarkers Market, By Application
13.1 Introduction
13.2 Development and Drug Formulation
13.3 Development of Molecular Diagnostics
13.4 Disease Diagnostics
13.5 Drug Discovery and Development
13.6 Personalised Medicine
13.7 Predictive
13.8 Prognostics
13.9 Research and Development
13.10 Risk Assessment
13.11 Therapeutic

14 Global Cancer Biomarkers Market, By End-User
14.1 Introduction
14.2 Academic and Cancer Research Institutes
14.3 Ambulatory Surgical Centers
14.4 Cancer Diagonostic Centers and Reasearch Laboratories
14.5 Clinic Laboratories
14.6 Contract Research Organizations(CRO)
14.7 Healthcare IT/Big Data Companies
14.8 Hospitals
14.9 Pharma & Biotech Companies

15 Global Cancer Biomarkers Market, By Geography
15.1 Introduction
15.2 North America
15.3 Europe
15.4 Asia Pacific
15.5 South America
15.6 Middle East & Africa

16 Strategic Benchmarking

17 Vendors Landscape
17.1 Abbott Laboratories
17.2 Agilent Technologies
17.3 Becton, Dickinson and Company
17.4 Biomérieux SA
17.5 Bio-Rad Laboratories
17.6 Danaher Corporation
17.7 GE Healthcare
17.8 Hologic
17.9 Illumina
17.10 Merck & Co
17.11 Myriad Genetics
17.12 Qiagen N.V.
17.13 Quest Diagnostics
17.14 Roche Diagnostics
17.15 Sysmex Corporation
17.16 Thermo Fisher Scientific

List of Data Tables
Table 1 Global Cancer Biomarkers Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Cancer Biomarkers Market Outlook, By Category (2016-2026) ($MN)
Table 3 Global Cancer Biomarkers Market Outlook, By Cancer Biomakers of Disease (2016-2026) ($MN)
Table 4 Global Cancer Biomarkers Market Outlook, By Cancer Biomakers of Exposure (2016-2026) ($MN)
Table 5 Global Cancer Biomarkers Market Outlook, By Method (2016-2026) ($MN)
Table 6 Global Cancer Biomarkers Market Outlook, By Assay Development (2016-2026) ($MN)
Table 7 Global Cancer Biomarkers Market Outlook, By Biomarkers and Testing (2016-2026) ($MN)
Table 8 Global Cancer Biomarkers Market Outlook, By Sample Preparation (2016-2026) ($MN)
Table 9 Global Cancer Biomarkers Market Outlook, By Biomarker Type (2016-2026) ($MN)
Table 10 Global Cancer Biomarkers Market Outlook, By Cancer Antigen 15-3 (CA 15-3) (2016-2026) ($MN)
Table 11 Global Cancer Biomarkers Market Outlook, By Cancer Antigen 27-29 (CA27-29) (2016-2026) ($MN)
Table 12 Global Cancer Biomarkers Market Outlook, By Carbohydrate Antigen 19-9 (CA 19-9) (2016-2026) ($MN)
Table 13 Global Cancer Biomarkers Market Outlook, By Carcinoembryonic antigen (CEA) (2016-2026) ($MN)
Table 14 Global Cancer Biomarkers Market Outlook, By Epigenetic Biomarkers (2016-2026) ($MN)
Table 15 Global Cancer Biomarkers Market Outlook, By Genetic Biomarkers (2016-2026) ($MN)
Table 16 Global Cancer Biomarkers Market Outlook, By Glass Transition Temperature (Tg) (2016-2026) ($MN)
Table 17 Global Cancer Biomarkers Market Outlook, By Glyco-biomarkers (2016-2026) ($MN)
Table 18 Global Cancer Biomarkers Market Outlook, By Glycomic Biomakers (2016-2026) ($MN)
Table 19 Global Cancer Biomarkers Market Outlook, By Glycoprotein Biomarkers (2016-2026) ($MN)
Table 20 Global Cancer Biomarkers Market Outlook, By Human Chorionic Gonadotropin (Hcg) (2016-2026) ($MN)
Table 21 Global Cancer Biomarkers Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2016-2026) ($MN)
Table 22 Global Cancer Biomarkers Market Outlook, By Human Epididymis Protein 4 (HE4) (2016-2026) ($MN)
Table 23 Global Cancer Biomarkers Market Outlook, By Metabolic Biomakers (2016-2026) ($MN)
Table 24 Global Cancer Biomarkers Market Outlook, By Microsatellite Instability (MSI) / Measles, Mumps and Rubella (MMR) (2016-2026) ($MN)
Table 25 Global Cancer Biomarkers Market Outlook, By Protein Biomarkers (2016-2026) ($MN)
Table 26 Global Cancer Biomarkers Market Outlook, By Proteomic Biomarkers (2016-2026) ($MN)
Table 27 Global Cancer Biomarkers Market Outlook, By Risk of Ovarian Malignancy Algorithm (ROMA) (2016-2026) ($MN)
Table 28 Global Cancer Biomarkers Market Outlook, By Tumor Mutational Burden (TMB) (2016-2026) ($MN)
Table 29 Global Cancer Biomarkers Market Outlook, By Tumor-Infiltrating Lymphocytes (TILs) (2016-2026) ($MN)
Table 30 Global Cancer Biomarkers Market Outlook, By Cancer Type (2016-2026) ($MN)
Table 31 Global Cancer Biomarkers Market Outlook, By Bladder Cancer (2016-2026) ($MN)
Table 32 Global Cancer Biomarkers Market Outlook, By Blood Cancer (2016-2026) ($MN)
Table 33 Global Cancer Biomarkers Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 34 Global Cancer Biomarkers Market Outlook, By Cervical Cancer (2016-2026) ($MN)
Table 35 Global Cancer Biomarkers Market Outlook, By Colorectal Cancer (CRC) (2016-2026) ($MN)
Table 36 Global Cancer Biomarkers Market Outlook, By Kidney Cancer (2016-2026) ($MN)
Table 37 Global Cancer Biomarkers Market Outlook, By Leukemia (2016-2026) ($MN)
Table 38 Global Cancer Biomarkers Market Outlook, By Liver Cancer (2016-2026) ($MN)
Table 39 Global Cancer Biomarkers Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 40 Global Cancer Biomarkers Market Outlook, By Melanoma (2016-2026) ($MN)
Table 41 Global Cancer Biomarkers Market Outlook, By Non-Hodgkin’s Lymphoma (2016-2026) ($MN)
Table 42 Global Cancer Biomarkers Market Outlook, By Ovarian Cancer (2016-2026) ($MN)
Table 43 Global Cancer Biomarkers Market Outlook, By Prostate Cancer (2016-2026) ($MN)
Table 44 Global Cancer Biomarkers Market Outlook, By Stomach Cancer (2016-2026) ($MN)
Table 45 Global Cancer Biomarkers Market Outlook, By Thyroid Cancer (2016-2026) ($MN)
Table 46 Global Cancer Biomarkers Market Outlook, By Technology (2016-2026) ($MN)
Table 47 Global Cancer Biomarkers Market Outlook, By Bioinformatics (2016-2026) ($MN)
Table 48 Global Cancer Biomarkers Market Outlook, By Cytogenetics-based Tests (2016-2026) ($MN)
Table 49 Global Cancer Biomarkers Market Outlook, By Imaging Technologies (2016-2026) ($MN)
Table 50 Global Cancer Biomarkers Market Outlook, By Immunoassays (2016-2026) ($MN)
Table 51 Global Cancer Biomarkers Market Outlook, By IVD Multivariate Index Assays (2016-2026) ($MN)
Table 52 Global Cancer Biomarkers Market Outlook, By Omic technologies (2016-2026) ($MN)
Table 53 Global Cancer Biomarkers Market Outlook, By Test Type (2016-2026) ($MN)
Table 54 Global Cancer Biomarkers Market Outlook, By Alpha-Fetoprotein (AFP) Tests (2016-2026) ($MN)
Table 55 Global Cancer Biomarkers Market Outlook, By Anaplastic Lymphoma Receptor Tyrosine Kinase Gene (ALK) Tests (2016-2026) ($MN)
Table 56 Global Cancer Biomarkers Market Outlook, By BReast CAncer gene (BRCA) Tests (2016-2026) ($MN)
Table 57 Global Cancer Biomarkers Market Outlook, By Cancer Antigen (CA) Tests (2016-2026) ($MN)
Table 58 Global Cancer Biomarkers Market Outlook, By Carcinoembryonic Antigen (CEA) Tests (2016-2026) ($MN)
Table 59 Global Cancer Biomarkers Market Outlook, By Circulating Tumor Cell (CTC) Tests (2016-2026) ($MN)
Table 60 Global Cancer Biomarkers Market Outlook, By Companion Diagnostic Tests (CDx) (2016-2026) ($MN)
Table 61 Global Cancer Biomarkers Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) Mutation Tests (2016-2026) ($MN)
Table 62 Global Cancer Biomarkers Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) Tests (2016-2026) ($MN)
Table 63 Global Cancer Biomarkers Market Outlook, By Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation Tests (2016-2026) ($MN)
Table 64 Global Cancer Biomarkers Market Outlook, By Laboratory Developed Tests (LDTs) (2016-2026) ($MN)
Table 65 Global Cancer Biomarkers Market Outlook, By Prostate-specific Antigen (PSA) Tests (2016-2026) ($MN)
Table 66 Global Cancer Biomarkers Market Outlook, By Analytical Technique (2016-2026) ($MN)
Table 67 Global Cancer Biomarkers Market Outlook, By Immunohistochemistry (IHC) (2016-2026) ($MN)
Table 68 Global Cancer Biomarkers Market Outlook, By Next Generation Sequencing (NGS) (2016-2026) ($MN)
Table 69 Global Cancer Biomarkers Market Outlook, By Polymerase Chain Reaction (PCR) (2016-2026) ($MN)
Table 70 Global Cancer Biomarkers Market Outlook, By Product (2016-2026) ($MN)
Table 71 Global Cancer Biomarkers Market Outlook, By cDNA clone based (2016-2026) ($MN)
Table 72 Global Cancer Biomarkers Market Outlook, By ELISA pair sets based (2016-2026) ($MN)
Table 73 Global Cancer Biomarkers Market Outlook, By RNA based (2016-2026) ($MN)
Table 74 Global Cancer Biomarkers Market Outlook, By Tumor suppressor based (2016-2026) ($MN)
Table 75 Global Cancer Biomarkers Market Outlook, By Application (2016-2026) ($MN)
Table 76 Global Cancer Biomarkers Market Outlook, By Development and Drug Formulation (2016-2026) ($MN)
Table 77 Global Cancer Biomarkers Market Outlook, By Development of Molecular Diagnostics (2016-2026) ($MN)
Table 78 Global Cancer Biomarkers Market Outlook, By Disease Diagnostics (2016-2026) ($MN)
Table 79 Global Cancer Biomarkers Market Outlook, By Drug Discovery and Development (2016-2026) ($MN)
Table 80 Global Cancer Biomarkers Market Outlook, By Personalised Medicine (2016-2026) ($MN)
Table 81 Global Cancer Biomarkers Market Outlook, By Predictive (2016-2026) ($MN)
Table 82 Global Cancer Biomarkers Market Outlook, By Prognostics (2016-2026) ($MN)
Table 83 Global Cancer Biomarkers Market Outlook, By Research and Development (2016-2026) ($MN)
Table 84 Global Cancer Biomarkers Market Outlook, By Risk Assessment (2016-2026) ($MN)
Table 85 Global Cancer Biomarkers Market Outlook, By Therapeutic (2016-2026) ($MN)
Table 86 Global Cancer Biomarkers Market Outlook, By End-User (2016-2026) ($MN)
Table 87 Global Cancer Biomarkers Market Outlook, By Academic and Cancer Research Institutes (2016-2026) ($MN)
Table 88 Global Cancer Biomarkers Market Outlook, By Ambulatory Surgical Centers (2016-2026) ($MN)
Table 89 Global Cancer Biomarkers Market Outlook, By Cancer Diagonostic Centers and Reasearch Laboratories (2016-2026) ($MN)
Table 90 Global Cancer Biomarkers Market Outlook, By Clinic Laboratories (2016-2026) ($MN)
Table 91 Global Cancer Biomarkers Market Outlook, By Contract Research Organizations(CRO) (2016-2026) ($MN)
Table 92 Global Cancer Biomarkers Market Outlook, By Healthcare IT/Big Data Companies (2016-2026) ($MN)
Table 93 Global Cancer Biomarkers Market Outlook, By Hospitals (2016-2026) ($MN)
Table 94 Global Cancer Biomarkers Market Outlook, By Pharma & Biotech Companies (2016-2026) ($MN)
Table 95 North America Cancer Biomarkers Market Outlook, By Category (2016-2026) ($MN)
Table 96 North America Cancer Biomarkers Market Outlook, By Method (2016-2026) ($MN)
Table 97 North America Cancer Biomarkers Market Outlook, By Biomarker Type (2016-2026) ($MN)
Table 98 North America Cancer Biomarkers Market Outlook, By Cancer Type (2016-2026) ($MN)
Table 99 North America Cancer Biomarkers Market Outlook, By Technology (2016-2026) ($MN)
Table 100 North America Cancer Biomarkers Market Outlook, By Test Type (2016-2026) ($MN)
Table 101 North America Cancer Biomarkers Market Outlook, By Analytical Technique (2016-2026) ($MN)
Table 102 North America Cancer Biomarkers Market Outlook, By Product (2016-2026) ($MN)
Table 103 North America Cancer Biomarkers Market Outlook, By Application (2016-2026) ($MN)
Table 104 North America Cancer Biomarkers Market Outlook, By End-User (2016-2026) ($MN)
Table 105 Europe Cancer Biomarkers Market Outlook, By Category (2016-2026) ($MN)
Table 106 Europe Cancer Biomarkers Market Outlook, By Method (2016-2026) ($MN)
Table 107 Europe Cancer Biomarkers Market Outlook, By Biomarker Type (2016-2026) ($MN)
Table 108 Europe Cancer Biomarkers Market Outlook, By Cancer Type (2016-2026) ($MN)
Table 109 Europe Cancer Biomarkers Market Outlook, By Technology (2016-2026) ($MN)
Table 110 Europe Cancer Biomarkers Market Outlook, By Test Type (2016-2026) ($MN)
Table 111 Europe Cancer Biomarkers Market Outlook, By Analytical Technique (2016-2026) ($MN)
Table 112 Europe Cancer Biomarkers Market Outlook, By Product (2016-2026) ($MN)
Table 113 Europe Cancer Biomarkers Market Outlook, By Application (2016-2026) ($MN)
Table 114 Europe Cancer Biomarkers Market Outlook, By End-User (2016-2026) ($MN)
Table 115 Asia Pacific Cancer Biomarkers Market Outlook, By Category (2016-2026) ($MN)
Table 116 Asia Pacific Cancer Biomarkers Market Outlook, By Method (2016-2026) ($MN)
Table 117 Asia Pacific Cancer Biomarkers Market Outlook, By Biomarker Type (2016-2026) ($MN)
Table 118 Asia Pacific Cancer Biomarkers Market Outlook, By Cancer Type (2016-2026) ($MN)
Table 119 Asia Pacific Cancer Biomarkers Market Outlook, By Technology (2016-2026) ($MN)
Table 120 Asia Pacific Cancer Biomarkers Market Outlook, By Test Type (2016-2026) ($MN)
Table 121 Asia Pacific Cancer Biomarkers Market Outlook, By Analytical Technique (2016-2026) ($MN)
Table 122 Asia Pacific Cancer Biomarkers Market Outlook, By Product (2016-2026) ($MN)
Table 123 Asia Pacific Cancer Biomarkers Market Outlook, By Application (2016-2026) ($MN)
Table 124 Asia Pacific Cancer Biomarkers Market Outlook, By End-User (2016-2026) ($MN)
Table 125 South America Cancer Biomarkers Market Outlook, By Category (2016-2026) ($MN)
Table 126 South America Cancer Biomarkers Market Outlook, By Method (2016-2026) ($MN)
Table 127 South America Cancer Biomarkers Market Outlook, By Biomarker Type (2016-2026) ($MN)
Table 128 South America Cancer Biomarkers Market Outlook, By Cancer Type (2016-2026) ($MN)
Table 129 South America Cancer Biomarkers Market Outlook, By Technology (2016-2026) ($MN)
Table 130 South America Cancer Biomarkers Market Outlook, By Test Type (2016-2026) ($MN)
Table 131 South America Cancer Biomarkers Market Outlook, By Analytical Technique (2016-2026) ($MN)
Table 132 South America Cancer Biomarkers Market Outlook, By Product (2016-2026) ($MN)
Table 133 South America Cancer Biomarkers Market Outlook, By Application (2016-2026) ($MN)
Table 134 South America Cancer Biomarkers Market Outlook, By End-User (2016-2026) ($MN)
Table 135 Middle East & Africa Cancer Biomarkers Market Outlook, By Category (2016-2026) ($MN)
Table 136 Middle East & Africa Cancer Biomarkers Market Outlook, By Method (2016-2026) ($MN)
Table 137 Middle East & Africa Cancer Biomarkers Market Outlook, By Biomarker Type (2016-2026) ($MN)
Table 138 Middle East & Africa Cancer Biomarkers Market Outlook, By Cancer Type (2016-2026) ($MN)
Table 139 Middle East & Africa Cancer Biomarkers Market Outlook, By Technology (2016-2026) ($MN)
Table 140 Middle East & Africa Cancer Biomarkers Market Outlook, By Test Type (2016-2026) ($MN)
Table 141 Middle East & Africa Cancer Biomarkers Market Outlook, By Analytical Technique (2016-2026) ($MN)
Table 142 Middle East & Africa Cancer Biomarkers Market Outlook, By Product (2016-2026) ($MN)
Table 143 Middle East & Africa Cancer Biomarkers Market Outlook, By Application (2016-2026) ($MN)
Table 144 Middle East & Africa Cancer Biomarkers Market Outlook, By End-User (2016-2026) ($MN)


Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Biomérieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • GE Healthcare
  • Hologic
  • Illumina
  • Merck & Co
  • Myriad Genetics
  • Qiagen N.V.
  • Quest Diagnostics
  • Roche Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll